Elise C. Benson’s Post

Bringing OhmX to the masses! Message me if you would like to learn how this program can help your lab advance your structural variant analysis with high-resolution electronic genome mapping

🌊Join us from May 13th to 15th for the 15th International Symposium on Variants in the Genome and dive into the world of genomics in Porto, Portugal! Meet our incredible team, including Paul R. Global Channel Partner Manager and Andrea Langella Product Manager alongside our Channel Partners Mário Simas and Sonia Martins from Bioportugal - Químico, Farmacêutica, Lda. Don’t miss Andrea Langella’s presentation – ‘Expanding the Nexome: Unveiling disease in non-coding regions with Nexome’ on Monday 13th May at 15:00. The talk will explore: ✅The limitations of standard WES ✅The importance of non-coding DNA in gene regulation and its role in human disease ✅Real-world examples to showcase how Nexome has identified disease-causing variants in non-coding regions ✅How Nexome maximizes diagnostic yield without inflating sequencing costs, compared to WES #ISV2024 #isvariants #Genomics #Porto #GenomicResearch #MedicalGenomics #PortoEvents #Biotech #ResearchInnovation #Genetics #Bioinformatics #Nexome #DNASequencing #PrecisionMedicine

We are happy to introduce you to our brand-new learning hub on all things single-cell multiomics. 🔍Discover how integrating genomic, transcriptomic, proteomic and other omics data is revolutionizing our understanding of cellular processes at the single-cell level. 🔍Learn more about how researchers are using insights from single-cell multiomics 🔍Find tools and resources to get started with your own single-cell multiomics research Learn more https://bit.ly/3BriZ1M #singlecell #Multiomics #Genomics #Proteomics #Epigenomics #Research #Innovation #Biotech #BDBiosciences

Bridge RNAs are structured noncoding #RNA that facilitate programmable recombination between target and donor #DNA, enabling precise genomic rearrangements. A significant advantage is their modularity. Here, CSTEAM-Biotech's Jack Huang MD, PhD shares key challenges to overcome with bridge RNAs, why they play an important role in #syntheticbiology, and more. #genomeediting #crispr #crisprcas9 #biotech https://lnkd.in/eCvpDXEr

You could run this exact experiment on Uncle and directly measure size by DLS, confirm aggregation by SLS, DNA leak by fluorescence with SYBR Gold. And with higher throughput than the other instruments listed. Details here: https://lnkd.in/eb54K2SB

Unlocking the secrets of transcriptional regulation! Assessing NGS-based approaches, benchmarking their accuracy, and revealing promising performers like BART, ChIP-Atlas, and Lisa. Discover More: https://lnkd.in/gQb446uD #bioinformatics #genomics #transcriptomics #ngs #bart #computationalbiology

🧬 The DNA Synthesis Market is set for a remarkable journey! 🌐 Projections suggest it will grow to a whopping USD 20.5 billion by 2032. 🚀 Witness the transformative power of biotech and genomics shaping our future! #DNASynthesis #Biotech #Genomics #FutureTech

Upcoming #Webinar 🚨 💻Join us for the webinar “A New Approach to Vector-Free CRISPR Editing Starting From Single Cells” !!! #CRISPR #CellEDIDT #CancerResearch #Scientist

Elevate Your Genomic Analysis with NGSAAP 🧬🚀 NGSAAP has best-in-class accuracy 2nd analysis, delivering unparalleled fast and reliability. Key benefits: Accuracy: Achieve exceptional results, even with complex datasets. Speed: Complete 30x whole-genome sequencing in under 30 minutes. Versatility: Compatible with leading sequencing platforms. Discover more on NGSAAP benchmark and performance. https://lnkd.in/gp-Je4u7 #genomics #NGS #innovation #bioinformatics #precisionmedicine

🌍 Metagenomic Sequencing Market to Double by 2028: Trends and Insights 📊 Download PDF Brochure :-https://lnkd.in/d9D3D_Yt 🚀 Exciting news in the world of metagenomic sequencing! The global market, estimated at $2.0 billion in 2023, is set to soar to $4.5 billion by 2028, growing at an impressive CAGR of 17.5%. 📈 Our latest research study dives deep into industry trends, pricing analysis, patent insights, and key stakeholder behaviors. With continuous technological innovations in NGS platforms, we've seen reduced timelines and costs in genome sequencing and related applications, including metagenomic sequencing. 🔬💡 However, challenges remain. Developing countries face lower adoption rates for sequencing products and services due to funding limitations and budget constraints. 🌍💰 Explore the future of metagenomic sequencing with our comprehensive analysis! 📚✨ #metagenomics #sequencing #NGS #ResearchAndDevelopment #genomics